Substance abuse and the risk of severe COVID-19: Mendelian randomization confirms the causal role of opioids but hints a negative causal effect for cannabinoids.  Jabalameli MR, Zhang ZD.  Front Genet. 2022 Dec 13;13:1070428. doi: 10.338…

Nonfatal opioid-related overdoses treated by emergency medical services in Florida, before and during the COVID-19 pandemic.  Ward MK, Gwanzura T, Rojas RR, Trepka MJ, Bursac Z, Wagner EF.  Prev Med Rep. 2023 Feb;31:102102. doi: 10.1016/…

Impact of the COVID-19 pandemic on alcohol or drug use symptoms and service need among youth: a cross-sectional sample from British Columbia, Canada.  Marchand K, Liu G, Mallia E, Ow N, Glowacki K, Hastings KG, Mathias S, Sutherland JM, Barbic…

Depressive Symptomatik in der Allgemeinbevölkerung vor und im ersten Jahr der COVID-19-Pandemie: Ergebnisse der GEDA-Studie 2019/2020 Ulfert Hapke, Christina Kersjes, Jens Hoebel, Ronny Kuhnert, Sophie Eicher, Stefan Damerow Journal of Health Moni…

COVID-related social determinants of substance use disorder among diverse U.S. racial ethnic groups.  Tao X, Liu T, Fisher CB, Giorgi S, Curtis B.  Soc Sci Med. 2022 Dec 5;317:115599. doi: 10.1016/j.socscimed.2022.115599. Epub ahead of p…

Outcomes of patients with COVID-19 in the setting of chronic opioid use disorder.  Thiesset HF, Newman M, Tonna JE, Merrill RM.  J Opioid Manag. 2022 Nov-Dec;18(6):523-528. doi: 10.5055/jom.2022.0747. PMID: 36523203. Abstract https://p…